Esperion Therapeutics
ESPR
#6751
Rank
S$0.64 B
Marketcap
$3.25
Share price
-3.57%
Change (1 day)
151.70%
Change (1 year)

Esperion Therapeutics (ESPR) - Cash on Hand

Cash on Hand as of June 2024 : S$0.25 Billion

According to Esperion Therapeutics's latest financial reports the company has S$0.25 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Esperion Therapeutics - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$0.10 B-51.44%
2022-12-31S$0.22 B-36.2%
2021-12-31S$0.35 B-13.1%
2020-12-31S$0.40 B49.04%
2019-12-31S$0.27 B45.67%
2018-12-31S$0.18 B-30.6%
2017-12-31S$0.26 B-12.56%
2016-12-31S$0.30 B1.99%
2015-12-31S$0.30 B114.69%
2014-12-31S$0.13 B83.78%
2013-12-31S$76.09 M855.64%
2012-12-31S$7.96 M291.37%
2011-12-31S$2.03 M
2002-12-31S$77.82 M-40.19%
2001-12-31S$0.13 B6.9%
2000-12-31S$0.12 B1138.19%
1999-12-31S$9.83 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$1.02 B 303.49%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.24 B 391.51%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.31 B 5,157.15%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.10 B 5,075.01%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.33 B 31.93%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.41 B 63.74%๐Ÿ‡บ๐Ÿ‡ธ USA